Pediatrics Doctors in Pickerington, OH Accepting Medicare

9 Pediatrics doctors found. Showing 1 - 9

Julie Rubino Dunlea, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

William Walter Long, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

Shadi R Jurdi, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 1030 Refugee Rd Ste 296, Pickerington, OH 43147 Phone: 614-788-4300    Fax: 614-533-0191

Amy Elizabeth Deibel, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

Shari Lyn Burns, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

Dr. Megan E Heitzman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

H Scott Tyson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

Carrie Jean Barnes-mullett, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222    Fax: 614-863-7388

Julie Newsom, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 905 Old Diley Rd, Pickerington, OH 43147 Phone: 614-864-3222

News Archive

FDA grants orphan drug designation for Synageva BioPharma's SBC-102

Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.

New resolvin reduces levels of pro-inflammatory molecules and cells in inflammation caused by E. coli

Inflammation is a protective response to invading microbes and tissue damage. Upon microbe clearance from the body or completion of wound healing, the inflammatory response must be dampened down.

Media outlets examine efforts to develop malaria vaccines

Scientists have identified a group of proteins they say could form the basis of a malaria vaccine, Australia's ABC News reports. "However, they say more laboratory work and clinical trials need to be done, with a vaccine at least 10 years away," the news service reports (Macey, 1/19).

Abused women more likely to seek emergency contraception, study finds

Women who experience domestic violence and abuse are more than twice as likely to seek emergency contraception as other women, according to a study by National Institute for Health Research-funded researchers at the University of Bristol and Queen Mary University of London, suggesting that requests for emergency contraception could be an important sign of abuse.

FDA approves label changes for Stryker Wingspan Stent System

The U.S. Food and Drug Administration today approved changes to the labeling for the Stryker Wingspan Stent System, including the indications for use. These changes, which the FDA outlined in a safety communication also issued today, specify a more limited group of patients who may benefit from the system.

Read more Medical News

› Verified 3 days ago